Behcet’s disease

[키워드] 95% CI adjusted age and gender Anosmia Anticoagulants arthralgia Asymptomatic Behcet's disease case sery Clinical characteristics Clinical outcome Cohort cohort of patient Colchicine Complete COVID-19 COVID-19 infection cumulative cumulative incidence defined died disease course dose drug discontinuation exacerbate fatigue Favipiravir Fever Follow-up followed by General population headache Hospitalized Hydroxychloroquine immunosuppressive incidence incidence of COVID-19 indicated infected with SARS-CoV-2 Infection information intensive care intensive care unit interferon interferon-alpha İstanbul laboratory-confirmed large cohort likelihood lung involvement management median Mortality Multiple Multiple regression analysis not differ outcome outpatient clinic pandemic Patient patients PCR positive positive Prognosis Prospective Study protective effect Registered regression analysis remaining reported SARS-CoV-2 SARS-CoV-2 PCR severity of COVID-19 Significant significantly smoking smoking. Symptom syndrome tested the patient thrombotic thrombotic event Thrombotic events took place Treatment Turkey were given
[DOI] 10.1007/s00296-021-05056-2 PMC 바로가기 [Article Type] Article